| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Depts of Pathobiology and 2 Basic Sciences, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
CORRESPONDENCE: G. Sadeghi-Hashjin, P.O. Box 641, Urmia, Iran. Fax: 98 4413443442. E-mail: g.sadeghi@mail.urmia.ac.ir
Keywords: lungs, oxygen radicals, pathology, peroxynitrite, rabbit, trachea
Received: July 25, 2001
Accepted April 15, 2002
The Research Office of Urmia University, Urmia, Iran, supported this work.
Abstract
Peroxynitrite (ONOO–) is the reaction product between nitric oxide and the superoxide anion. It is a biological oxidant and cytotoxic anion, produced in vivo, which might cause inflammation and damage to the lungs. This study was designed to investigate whether direct contact with peroxynitrite could cause pathological changes in the airways.
Twenty New Zealand rabbits were divided into four experimental groups. They were anesthetised by intravascular injection of thiopental sodium, and peroxynitrite (0.5 mL of a 10 mM solution) was inoculated intratracheally. At 2 h, 24 h, 48 h, and 72 h postinoculation trachea and lungs were isolated for histopathology.
The histopathological observations in the lungs were congestion, serous exudation, infiltration of leukocytes and degeneration, which were found to be time-dependent. Changes were similar at 48 and 72 h. Degenerative changes were not progressive. The changes in the trachea were congestion, oedema, leukocyte infiltration, and degeneration of tracheal epithelium.
This study shows that peroxynitrite formation in the respiratory tract induces lung inflammation and degenerative changes.
|
| (001) |
Materials and methods
Peroxynitrite synthesis
Peroxynitrite was synthesised in a quenched flow reactor as described previously 6. Briefly, solutions of 0.6 M NaNO2 and 0.6 M HCl plus 0.7 M H2O2 were pumped into a T-junction and mixed in a glass tube. The acid-catalysed reaction of nitrous acid with H2O2 to form peroxynitrous acid was quenched by pumping 1.5 M NaOH at the same rate into a second T junction at the end of glass tubing. The solution was frozen for a week at –20°C. As a result of freeze fractionation, peroxynitrite formed a yellow top layer which was retained for further analysis and application. The concentration of peroxynitrite in this layer was determined by absorbance at 302 nm (
302=1.67x103·M–1·cm–1). Stock solutions of peroxynitrite were kept in a freezer at alkaline pH, and the concentration was determined before each use. At room temperature and at a concentration of 10 mM in Krebs' buffer, peroxynitrite decomposed by 
50%, 92%, and 100% after 15, 30, and 60 min, respectively.
Animals and the experimental protocol
Twenty healthy, New Zealand rabbits were selected. The sex of the rabbit was not considered and the animals were in the same weight range. Rabbits were given water and commercial feed ad lib. They were divided into four experimental groups and two animals were taken as control in each group. The rabbits were anesthetised by thiopental sodium (25 mg·kg–1 b.w., i.v.). The site was located and antiseptic solution was applied to the skin, the trachea was then palpated and peroxynitrite (0.5 ml of 10 mM solution) was inoculated intratracheally using a tuberculin syringe. Control animals received distilled water (0.5 ml) intratracheally. The rabbits were sacrificed at intervals of 2, 24, 48, and 72 h postinoculation by an overdose i.v. injection of sodium thiopental. All chemicals used in this study were purchased from Merck (Darmstadt, Germany).
Necropsy and histopathology
A detailed necropsy was performed, the trachea and lungs were dissected out, and samples for bacteriological cultures were taken from bronchial exudate. The lung and tracheal tissues were fixed in 10% neutral buffer formaline for histopathology. Sections of 4–5 µm were made and stained with haematoxylin and eosin and examined under the light microscope.
Results
Bacteriological cultures from bronchial exudate were found to be negative for all pathogenic organisms, both in the control and peroxynitrite-treated animals. No gross abnormalities were observed in the control animals. In the peroxynitrite-inoculated animals, pathological changes were limited to the respiratory system. The changes were progressive in nature, that is, from congestion of trachea and lung in the early hours to presence of pneumonic patches. However, no significant differences were observed between the pathological changes at 48 and 72 h after inoculation.
There were no significant pathological changes in the lungs (fig. 1a
) and trachea of the control animals at 2, 24, 48 and 72 h postinoculation. In the experimental group at 2 h postinoculation, there was congestion, oedema and leukocyte infiltration in the trachea with some areas of necrosis. Changes in the lungs were focal severe congestion with serous exudation (fig. 1b). Bronchial epithelium showed degenerative changes in some areas. Focal leukocytic infiltration consisting of lymphocytes and neutrophils was also seen.
|
). Infiltration of leukocytes, mainly lymphocytes, into the alveolar spaces was also seen. Bronchial epithelium showed different degrees of degeneration. At 48 h postinoculation, there was diffuse leukocytic infiltration; alveolar spaces were filled with exudate. The cells were neutrophils, lymphocytes and macrophages. Bronchial spaces were filled with leukocytes (fig. 1d). These changes showed a clear picture of bronchopneumonia. The tracheal changes were oedema and leukocytic infiltration and necrosis. Changes at 72 h postinoculation were similar to those seen at 48 h. Discussion
This study shows that a single intratracheal application of peroxynitrite in rabbits may cause inflammatory and degenerative effects in the respiratory tract. In the present study, a high dose of peroxynitrite was administered directly to the airways, causing the severe effects found. Inflammation and tissue damage were observed as rapidly as 2 h postinoculation. This clearly showed that peroxynitrite could not only bring about an inflammatory reaction but could also induce cell injury. The immediate inflammatory effect was followed by a cellular infiltration during 24, 48, and 72 h postinoculation, which could be the delayed response to peroxynitrite.
Under (patho)physiological conditions, peroxynitrite could potentially be formed by different cells and hence could bring about similar pathological lesions. The half-life of peroxynitrite has been reported to be only 1 s at pH 7.4 and 37°C 7. Many inflammatory cells, such as macrophages, produce and release superoxide anions and nitric oxide as part of their microbicidal effector molecules. The simultaneous production of these radicals results in the rapid formation of peroxynitrite 8. In turn, peroxynitrite oxidises lipids and proteins and via this route cellular activities could be suppressed 2. Sadeghi-Hashjin et al. 2 stated that peroxynitrite could be an important factor in tissue injury and chronic inflammatory conditions in which free radicals are released. Such changes probably occur in a nonspecific manner, as similar changes may be observed in the kidney and liver 9. The serious pathological effects of peroxynitrite could be due to a failure of defence mechanisms against peroxynitrite 1.
There is increasing evidence that peroxynitrite is produced in the respiratory tract, especially by macrophages. It may have a role in the oxidative damage in the lung and might be involved in airway hyperresponsiveness, asthma, pulmonary inflammation, surfactant protein damage, occupational lung disease, adult respiratory distress syndrome, and cigarette smoke-induced pulmonary disorders 2. Superoxide anion is produced by the airway epithelium in detectable amounts 10. Peroxynitrite is likely to be produced from the reaction between this substance and nitric oxide. This study shows that peroxynitrite formation in the respiratory tract may be involved in lung inflammation and degenerative changes.
Acknowledgements
The authors are grateful to A. Jamshidi and T. Kahroba for their technical assistance.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
